Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Agmatine and Nicotine

supplement:

Agmatine

Research Papers that Mention the Interaction

Animals injected with agmatine (10–40&mgr;g/rat, icv) from day 7 to 14 before the first daily dose of nicotine (2mg/kg, sc) showed increased step through latencies during retrieval test.
Overall, the data indicate that agmatine attenuates nicotine withdrawal induced memory impairment through modulation of &agr;2adrenergic receptors.
Thus, agmatine might have therapeutic implications in the treatment of cognitive deficits following nicotine withdrawal.
Pharmacology Biochemistry and Behavior  •  2018  |  View Paper
This result clearly shows the role of agmatine in development of nicotine dependence and its withdrawal.
European journal of pharmacology  •  2015  |  View Paper
Agmatine (20 and 40 mg/kg, ip) co-administered with nicotine during the 6 days conditioning sessions completely abolished the acquisition of nicotine-induced CPP in mice.
Conversely, administration of agmatine prior to the nicotine significantly reversed the effect of nicotine on NPY-immunoreactivity in the above brain nuclei.
This data indicate that agmatine attenuate nicotine induced CPP via modulation of NPYergic neurotransmission in brain.
Behavioural Brain Research  •  2014  |  View Paper
These data indicate that agmatine attenuates nicotine induced locomotor sensitization via a mechanism which may involve alpha(2)-adrenergic receptors.
Behavioural Brain Research  •  2010  |  View Paper
The present study tested whether agmatine (5-40 mg/kg, sc) modulated the locomotor, sensitizing, and discriminative stimulus effects of nicotine in male Wistar rats.
Pharmacological reports : PR  •  2008  |  View Paper